| Autor: |
Jessen F; Professor Frank Jessen, MD, Department of Psychiatry, University of Cologne, Medical Faculty Kerpener Straße 62, 50924 Cologne, Germany, Tel.: +49-(0)221 478-4010, Fax: +49-(0)221 478-5593, E-mail: frank.jessen@uk-koeln.de. |
| Jazyk: |
angličtina |
| Zdroj: |
The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2019; Vol. 6 (3), pp. 179. |
| DOI: |
10.14283/jpad.2019.18 |
| Abstrakt: |
Competing Interests: Frank Jessen grants from and is a principle investigator for Eli Lilly, Biogen, EISAI, Roche, Novartis, and Boehringer; and personal fees for consultancy from Eli Lilly, Roche, MSD, Janssen Pharmaceutica, Biogen, and AC Immune. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink